Industry: Service & Software
Published Date: 2026-06-04
Pages: 132 Pages
Report ld: 6410318
Request Sample
Customized Report
Medical Device Pyrogenicity Testing Service Market Size(US$)

CAGR 2026-2032
5.8%
Market Size,2032
USD 242
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Medical Device Pyrogenicity Testing Service market size was US$ 162 million in 2025 and is forecast to reach a readjusted size of US$ 242 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Medical Device Pyrogenicity Testing Service refer to specialized third-party laboratory services used to evaluate pyrogenic and bacterial endotoxin risks associated with medical devices, device components, raw materials, sterilized finished products, and drug-device combination products.
Medical Device Pyrogenicity Testing Service market should be treated as a specialized compliance service embedded in sterility assurance, biological evaluation, and regulatory submission workflows, rather than as a broad microbiology testing market. Demand is primarily driven by implantable devices, blood-contacting devices, dialysis and infusion products, intraocular devices, catheters, syringes, drug-device combination products, and devices carrying sterile or non-pyrogenic claims. The appropriate statistical boundary should focus on medical device-related BET/LAL testing, material-mediated pyrogenicity evaluation, RPT, MAT, method suitability validation, inhibition/enhancement testing, and batch-release support. General pharmaceutical endotoxin testing, food or water microbiology, reagent-only businesses, and pure regulatory consulting should not be mixed into the revenue model. The regulatory foundation is shaped by FDA guidance, USP <85>, USP <161>, ANSI/AAMI ST72, ISO 10993-11, and ISO/TR 21582, which together define the practical testing logic, device applicability, and risk-based method selection framework.
From a supply perspective, the industry is structured around three layers: global laboratory networks, medical-device-focused CROs, and regional compliance testing laboratories. Nelson Labs / Sotera Health, Eurofins, NAMSA, Charles River, STERIS, SGS, TÜV SÜD, and Intertek form the global supply base, with capabilities across medical device testing, sterility assurance, batch release, microbiology, and multi-region regulatory support. Pacific BioLabs, Cormica / Wickham, Pace Life Sciences, Canyon Labs, Kamakura Techno-Science, Koga Isotope, and selected Asian laboratories serve as specialized or regional suppliers. The broad longlist is materially larger than the core formal list because some entities provide endotoxin testing without clear medical device positioning, some are mainly reagent or technology providers, and some regional laboratories have incomplete public evidence. These companies should be retained in an extended or watchlist layer rather than being forced into the core competitive landscape.
From a demand perspective, North America and Europe remain the highest-value markets due to established regulatory expectations, a large base of implantable and interventional devices, frequent use of outsourced batch-release testing, and a stronger preference for laboratories experienced with FDA, USP, ISO, AAMI, EP, and JP requirements. China, Japan, Southeast Asia, Taiwan, South Korea, and India represent incremental growth pools, supported by local medical device exports, more structured registration dossiers, upgrading quality systems, and gradual localization of testing capacity. In China, WuXi AppTec Medical Device Testing Center, Eurofins China, TÜV SÜD China, and CAS Testing have relatively clear evidence, while additional provincial device testing institutes, drug control laboratories, and regional private laboratories may still require further verification.
From a technology-route perspective, conventional LAL/BET remains the revenue backbone of the market, particularly for routine batch release and endotoxin limit testing. RPT remains relevant for broad pyrogenicity or material-mediated pyrogenicity assessments, but its growth potential is constrained by animal welfare considerations and the development of alternative methods. MAT, rFC, and rCR represent the most important technical evolution paths. FDA’s 2026 update to its pyrogen and endotoxins testing guidance, including broader accommodation of recombinant reagents, suggests that the regulatory environment is becoming more open to non-animal and sustainable testing routes. This transition is unlikely to replace conventional LAL testing immediately, but it will increase the value of method development, bridging validation, feasibility studies, and complex sample troubleshooting.
The global Medical Device Pyrogenicity Testing Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medical Device Pyrogenicity Testing Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Bacterial Endotoxin Testing
1.2.3 Monocyte Activation Test
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Device Manufacturing
1.3.3 Pharmaceutical Industry
1.3.4 Biopharmaceutical Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Device Pyrogenicity Testing Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Medical Device Pyrogenicity Testing Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Medical Device Pyrogenicity Testing Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Medical Device Pyrogenicity Testing Service Market Size and Prospective (2021-2032)
2.5.2 Europe Medical Device Pyrogenicity Testing Service Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size and Prospective (2021-2032)
2.5.4 Latin America Medical Device Pyrogenicity Testing Service Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Medical Device Pyrogenicity Testing Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Medical Device Pyrogenicity Testing Service Historical Market Size by Type (2021-2026)
3.2 Global Medical Device Pyrogenicity Testing Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Medical Device Pyrogenicity Testing Service
4 Breakdown Data by Application
4.1 Global Medical Device Pyrogenicity Testing Service Historical Market Size by Application (2021-2026)
4.2 Global Medical Device Pyrogenicity Testing Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Medical Device Pyrogenicity Testing Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Medical Device Pyrogenicity Testing Service Players by Revenue (2021-2026)
5.1.2 Global Medical Device Pyrogenicity Testing Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Medical Device Pyrogenicity Testing Service Revenue
5.4 Global Medical Device Pyrogenicity Testing Service Market Concentration Analysis
5.4.1 Global Medical Device Pyrogenicity Testing Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Medical Device Pyrogenicity Testing Service Revenue in 2025
5.5 Global Key Players of Medical Device Pyrogenicity Testing Service Head Offices and Areas Served
5.6 Global Key Players of Medical Device Pyrogenicity Testing Service, Product and Application
5.7 Global Key Players of Medical Device Pyrogenicity Testing Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Medical Device Pyrogenicity Testing Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Medical Device Pyrogenicity Testing Service Market Size by Type (2021-2026)
6.1.2.2 North America Medical Device Pyrogenicity Testing Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Medical Device Pyrogenicity Testing Service Market Size by Application (2021-2026)
6.1.3.2 North America Medical Device Pyrogenicity Testing Service Market Share by Application (2021-2026)
6.1.4 North America Medical Device Pyrogenicity Testing Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Medical Device Pyrogenicity Testing Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Medical Device Pyrogenicity Testing Service Market Size by Type (2021-2026)
6.2.2.2 Europe Medical Device Pyrogenicity Testing Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Medical Device Pyrogenicity Testing Service Market Size by Application (2021-2026)
6.2.3.2 Europe Medical Device Pyrogenicity Testing Service Market Share by Application (2021-2026)
6.2.4 Europe Medical Device Pyrogenicity Testing Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Medical Device Pyrogenicity Testing Service Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Medical Device Pyrogenicity Testing Service Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Medical Device Pyrogenicity Testing Service Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Medical Device Pyrogenicity Testing Service Market Size by Type (2021-2026)
6.4.2.2 Latin America Medical Device Pyrogenicity Testing Service Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Medical Device Pyrogenicity Testing Service Market Size by Application (2021-2026)
6.4.3.2 Latin America Medical Device Pyrogenicity Testing Service Market Share by Application (2021-2026)
6.4.4 Latin America Medical Device Pyrogenicity Testing Service Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Medical Device Pyrogenicity Testing Service Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Medical Device Pyrogenicity Testing Service Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Medical Device Pyrogenicity Testing Service Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Medical Device Pyrogenicity Testing Service Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Medical Device Pyrogenicity Testing Service Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Medical Device Pyrogenicity Testing Service Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Nelson Laboratories
7.1.1 Nelson Laboratories Company Details
7.1.2 Nelson Laboratories Business Overview
7.1.3 Nelson Laboratories Medical Device Pyrogenicity Testing Service Introduction
7.1.4 Nelson Laboratories Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.1.5 Nelson Laboratories Recent Development
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Company Details
7.2.2 Eurofins Scientific Business Overview
7.2.3 Eurofins Scientific Medical Device Pyrogenicity Testing Service Introduction
7.2.4 Eurofins Scientific Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.2.5 Eurofins Scientific Recent Development
7.3 NAMSA
7.3.1 NAMSA Company Details
7.3.2 NAMSA Business Overview
7.3.3 NAMSA Medical Device Pyrogenicity Testing Service Introduction
7.3.4 NAMSA Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.3.5 NAMSA Recent Development
7.4 Charles River
7.4.1 Charles River Company Details
7.4.2 Charles River Business Overview
7.4.3 Charles River Medical Device Pyrogenicity Testing Service Introduction
7.4.4 Charles River Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.4.5 Charles River Recent Development
7.5 WuXi AppTec MDT
7.5.1 WuXi AppTec MDT Company Details
7.5.2 WuXi AppTec MDT Business Overview
7.5.3 WuXi AppTec MDT Medical Device Pyrogenicity Testing Service Introduction
7.5.4 WuXi AppTec MDT Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.5.5 WuXi AppTec MDT Recent Development
7.6 STERIS
7.6.1 STERIS Company Details
7.6.2 STERIS Business Overview
7.6.3 STERIS Medical Device Pyrogenicity Testing Service Introduction
7.6.4 STERIS Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.6.5 STERIS Recent Development
7.7 SGS
7.7.1 SGS Company Details
7.7.2 SGS Business Overview
7.7.3 SGS Medical Device Pyrogenicity Testing Service Introduction
7.7.4 SGS Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.7.5 SGS Recent Development
7.8 TÜV SÜD
7.8.1 TÜV SÜD Company Details
7.8.2 TÜV SÜD Business Overview
7.8.3 TÜV SÜD Medical Device Pyrogenicity Testing Service Introduction
7.8.4 TÜV SÜD Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.8.5 TÜV SÜD Recent Development
7.9 Intertek
7.9.1 Intertek Company Details
7.9.2 Intertek Business Overview
7.9.3 Intertek Medical Device Pyrogenicity Testing Service Introduction
7.9.4 Intertek Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.9.5 Intertek Recent Development
7.10 Element
7.10.1 Element Company Details
7.10.2 Element Business Overview
7.10.3 Element Medical Device Pyrogenicity Testing Service Introduction
7.10.4 Element Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.10.5 Element Recent Development
7.11 Mérieux NutriSciences
7.11.1 Mérieux NutriSciences Company Details
7.11.2 Mérieux NutriSciences Business Overview
7.11.3 Mérieux NutriSciences Medical Device Pyrogenicity Testing Service Introduction
7.11.4 Mérieux NutriSciences Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.11.5 Mérieux NutriSciences Recent Development
7.12 Pacific BioLabs
7.12.1 Pacific BioLabs Company Details
7.12.2 Pacific BioLabs Business Overview
7.12.3 Pacific BioLabs Medical Device Pyrogenicity Testing Service Introduction
7.12.4 Pacific BioLabs Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.12.5 Pacific BioLabs Recent Development
7.13 Cormica
7.13.1 Cormica Company Details
7.13.2 Cormica Business Overview
7.13.3 Cormica Medical Device Pyrogenicity Testing Service Introduction
7.13.4 Cormica Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.13.5 Cormica Recent Development
7.14 Pace Life Sciences
7.14.1 Pace Life Sciences Company Details
7.14.2 Pace Life Sciences Business Overview
7.14.3 Pace Life Sciences Medical Device Pyrogenicity Testing Service Introduction
7.14.4 Pace Life Sciences Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.14.5 Pace Life Sciences Recent Development
7.15 Canyon Labs
7.15.1 Canyon Labs Company Details
7.15.2 Canyon Labs Business Overview
7.15.3 Canyon Labs Medical Device Pyrogenicity Testing Service Introduction
7.15.4 Canyon Labs Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.15.5 Canyon Labs Recent Development
7.16 LSO
7.16.1 LSO Company Details
7.16.2 LSO Business Overview
7.16.3 LSO Medical Device Pyrogenicity Testing Service Introduction
7.16.4 LSO Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.16.5 LSO Recent Development
7.17 Kamakura Techno-Science
7.17.1 Kamakura Techno-Science Company Details
7.17.2 Kamakura Techno-Science Business Overview
7.17.3 Kamakura Techno-Science Medical Device Pyrogenicity Testing Service Introduction
7.17.4 Kamakura Techno-Science Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.17.5 Kamakura Techno-Science Recent Development
7.18 Koga Isotope
7.18.1 Koga Isotope Company Details
7.18.2 Koga Isotope Business Overview
7.18.3 Koga Isotope Medical Device Pyrogenicity Testing Service Introduction
7.18.4 Koga Isotope Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.18.5 Koga Isotope Recent Development
7.19 CAS Testing
7.19.1 CAS Testing Company Details
7.19.2 CAS Testing Business Overview
7.19.3 CAS Testing Medical Device Pyrogenicity Testing Service Introduction
7.19.4 CAS Testing Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.19.5 CAS Testing Recent Development
7.20 ALS Malaysia
7.20.1 ALS Malaysia Company Details
7.20.2 ALS Malaysia Business Overview
7.20.3 ALS Malaysia Medical Device Pyrogenicity Testing Service Introduction
7.20.4 ALS Malaysia Revenue in Medical Device Pyrogenicity Testing Service Business (2021-2026)
7.20.5 ALS Malaysia Recent Development
8 Medical Device Pyrogenicity Testing Service Market Dynamics
8.1 Medical Device Pyrogenicity Testing Service Industry Trends
8.2 Medical Device Pyrogenicity Testing Service Market Drivers
8.3 Medical Device Pyrogenicity Testing Service Market Challenges
8.4 Medical Device Pyrogenicity Testing Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ 162 million in 2025 to US$ 242 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-06-04
Pages: 158
USD 4900.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ 162 million in 2025 and is projected to reach US$ 242 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-06-04
Pages: 132
USD 3950.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market was valued at US$ 162 million in 2025 and is anticipated to reach US$ 242 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-06-04
Pages: 135
USD 2900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 139
USD 4900.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 113
USD 3950.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 84
USD 2900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-04-07
Pages: 145
USD 4900.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-07
Pages: 108
USD 4350.00
(Single User License)
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-07
Pages: 116
USD 3950.00
(Single User License)
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ 162 million in 2025 to US$ 242 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-06-04
Pages: 158
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ 162 million in 2025 and is projected to reach US$ 242 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-06-04
Pages: 132
The global Medical Device Pyrogenicity Testing Service market was valued at US$ 162 million in 2025 and is anticipated to reach US$ 242 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-06-04
Pages: 135
The global Medical Device Pyrogenicity Testing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 139
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 113
The global market for Medical Device Pyrogenicity Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 84
The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-04-07
Pages: 145
The global Medical Device Pyrogenicity Testing Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-07
Pages: 108
The global market for Medical Device Pyrogenicity Testing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-07
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now